SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-044656
Filing Date
2021-11-15
Accepted
2021-11-15 18:57:52
Documents
1
Period of Report
2021-11-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4065
  Complete submission text file 0000899243-21-044656.txt   5434
Mailing Address 1717 MAIN STREET SUITE 3388 DALLAS TX 75201
Business Address 1717 MAIN STREET SUITE 3388 DALLAS TX 75201 (254) 244-5739
Vaxxinity, Inc. (Issuer) CIK: 0001851657 (see all company filings)

IRS No.: 862083865 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VAXXINITY, INC. 1717 MAIN ST STE. 3388 DALLAS TX 75201
Business Address
Paula Molina Rene (Reporting) CIK: 0001890868 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41058 | Film No.: 211413445